{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:29:15Z","timestamp":1761514155233,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0835-3","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T08:11:20Z","timestamp":1518509480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Renal manifestations of tuberous sclerosis complex: patients\u2019 and parents\u2019 knowledge and routines for renal follow-up \u2013 a questionnaire study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-3941","authenticated-orcid":false,"given":"I.","family":"Cockerell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Guenin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Heimdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bj\u00f8rnvold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. K.","family":"Selmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Rouvi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"835_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68:64\u201380.","journal-title":"Am J Hum Genet"},{"key":"835_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345\u201356.","journal-title":"N Engl J Med"},{"key":"835_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA. International tuberous sclerosis complex consensus group: tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243\u201354.","journal-title":"Pediatr Neurol"},{"key":"835_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","volume":"351","author":"FJ O'Callaghan","year":"1998","unstructured":"O'Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998;351:1490.","journal-title":"Lancet"},{"key":"835_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/jmg.26.1.28","volume":"26","author":"JR Sampson","year":"1989","unstructured":"Sampson JR, Scahill SJ, Stephenson JB, Mann L, Connor JM. Genetic aspects of tuberous sclerosis in the west of Scotland. J Med Genet. 1989;26:28\u201331.","journal-title":"J Med Genet"},{"key":"835_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"835_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H. International tuberous sclerosis complex consensus G: tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:255\u201365.","journal-title":"Pediatr Neurol"},{"key":"835_CR8","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1097\/01.ju.0000058253.40352.60","volume":"169","author":"TS Lendvay","year":"2003","unstructured":"Lendvay TS, Marshall FF. The tuberous sclerosis complex and its highly variable manifestations. J Urol. 2003;169:1635\u201342.","journal-title":"J Urol"},{"key":"835_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14:733\u201345.","journal-title":"Lancet Neurol"},{"key":"835_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","volume":"66","author":"MJ Eijkemans","year":"2015","unstructured":"Eijkemans MJ, van der Wal W, Reijnders LJ, Roes KC, van Waalwijk van Doorn-Khosrovani SB, Pelletier C, Magestro M, Zonnenberg B. Long-term follow-up assessing renal Angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am J Kidney Dis. 2015;66:638\u201345.","journal-title":"Am J Kidney Dis"},{"key":"835_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","volume":"94","author":"FJ O'Callaghan","year":"2004","unstructured":"O'Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int. 2004;94:853\u20137.","journal-title":"BJU Int"},{"key":"835_CR12","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 2006;70:1777\u201382.","journal-title":"Kidney Int"},{"key":"835_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.diii.2013.01.003","volume":"94","author":"O Rouviere","year":"2013","unstructured":"Rouviere O, Nivet H, Grenier N, Zini L, Lechevallier E. Kidney damage due to tuberous sclerosis complex: management recommendations. Diagn Interv Imaging. 2013;94:225\u201337.","journal-title":"Diagn Interv Imaging"},{"key":"835_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.urology.2016.04.027","volume":"95","author":"J Bissler","year":"2016","unstructured":"Bissler J, Cappell K, Charles H, Song X, Liu Z, Prestifilippo J, Gregory C, Hulbert J. Long-term clinical morbidity in patients with renal Angiomyolipoma associated with tuberous sclerosis complex. Urology. 2016;95:80\u20137.","journal-title":"Urology"},{"key":"835_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc. 1991;66:792\u20136.","journal-title":"Mayo Clin Proc"},{"key":"835_CR16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0022-5347(05)64440-0","volume":"168","author":"CP Nelson","year":"2002","unstructured":"Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168:1315\u201325.","journal-title":"J Urol"},{"key":"835_CR17","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1159\/000320891","volume":"118","author":"BP Dixon","year":"2011","unstructured":"Dixon BP, Hulbert JC, Bissler JJ. Tuberous sclerosis complex renal disease. Nephron Exp Nephrol. 2011;118:e15\u201320.","journal-title":"Nephron Exp Nephrol"},{"key":"835_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/088307389901400610","volume":"14","author":"ES Roach","year":"1999","unstructured":"Roach ES, DiMario FJ, Kandt RS, Northrup H. Tuberous sclerosis consensus conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol. 1999;14:401\u20137.","journal-title":"J Child Neurol"},{"key":"835_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2017.02.023","volume":"104","author":"I Cockerell","year":"2017","unstructured":"Cockerell I, Guenin M, Heimdal K, Bjornvold M, Selmer KK, Rouviere O. Prevalence of renal Angiomyolipomas and spontaneous bleeding related to Angiomyolipomas in tuberous sclerosis complex patients in France and Norway-a questionnaire study. Urology. 2017;104:70\u20136.","journal-title":"Urology"},{"key":"835_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","volume":"70","author":"JR Bhatt","year":"2016","unstructured":"Bhatt JR, Richard PO, Kim NS, Finelli A, Manickavachagam K, Legere L, Evans A, Pei Y, Sykes J, Jhaveri K, Jewett MA. Natural history of renal Angiomyolipoma (AML): most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy. Eur Urol. 2016;70:85\u201390.","journal-title":"Eur Urol"},{"key":"835_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiol.2251011477","volume":"225","author":"K Yamakado","year":"2002","unstructured":"Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology. 2002;225:78\u201382.","journal-title":"Radiology"},{"key":"835_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.crad.2006.02.003","volume":"61","author":"U Rimon","year":"2006","unstructured":"Rimon U, Duvdevani M, Garniek A, Golan G, Bensaid P, Ramon J, Morag B. Large renal angiomyolipomas: digital subtraction angiographic grading and presentation with bleeding. Clin Radiol. 2006;61:520\u20136.","journal-title":"Clin Radiol"},{"key":"835_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.diii.2015.12.004","volume":"97","author":"J Champagnac","year":"2016","unstructured":"Champagnac J, Melodelima C, Martinelli T, Pagnoux G, Badet L, Juillard L, Rouviere O. Microaneurysms in renal angiomyolipomas: can clinical and computed tomography features predict their presence and size? Diagn Interv Imaging. 2016;97:321\u20136.","journal-title":"Diagn Interv Imaging"},{"key":"835_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1148\/radiol.2252011584","volume":"225","author":"KA Casper","year":"2002","unstructured":"Casper KA, Donnelly LF, Chen B, Bissler JJ. Tuberous sclerosis complex: renal imaging findings. Radiology. 2002;225:451\u20136.","journal-title":"Radiology"},{"key":"835_CR25","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.juro.2007.07.058","volume":"178","author":"M Castagnetti","year":"2007","unstructured":"Castagnetti M, Vezzu B, Laverda A, Zampieri S, Rigamonti W. Urological counseling and followup in pediatric tuberous sclerosis complex. J Urol. 2007;178:2155\u20139.","journal-title":"J Urol"},{"key":"835_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","volume":"160","author":"DH Ewalt","year":"1998","unstructured":"Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES. Renal lesion growth in children with tuberous sclerosis complex. J Urol. 1998;160:141\u20135.","journal-title":"J Urol"},{"key":"835_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.juro.2016.09.082","volume":"197","author":"JC Warncke","year":"2017","unstructured":"Warncke JC, Brodie KE, Grantham EC, Catarinicchia SP, Tong S, Kondo KL, Cost NG. Pediatric renal Angiomyolipomas in tuberous sclerosis complex. J Urol. 2017;197:500\u20136.","journal-title":"J Urol"},{"key":"835_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3148.2011.00643.x","volume":"25","author":"V Turk","year":"2012","unstructured":"Turk V, Leer G, Burchell S, Khattram S, Comey R, Rowlands G. Adults with intellectual disabilities and their Carers as researchers and participants in a RCT. J Appl Res Intellect Disabil. 2012;25:1\u201310.","journal-title":"J Appl Res Intellect Disabil"},{"key":"835_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1464-410X.2009.08649.x","volume":"105","author":"P Sooriakumaran","year":"2010","unstructured":"Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C, Taylor J, Corbishley C, Patel U, Anderson C. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 2010;105:101\u20136.","journal-title":"BJU Int"},{"key":"835_CR30","unstructured":"Taylor H. The Growing Influence and Use Of Health Care Information Obtained Online. The Harris Poll - Health & Life. 2011. \n                    https:\/\/www.prnewswire.com\/news-releases\/the-growing-influence-and-use-of-health-care-information-obtained-online-129893198.html\n                    \n                  . Accessed 5 Feb 2018."},{"key":"835_CR31","unstructured":"Department of Rare Disorders and Disabilities, Oslo University Hospital, Norway. National Centre for rare epilepsy-related disorders. In: Tuber\u00f8s sklerose kompleks - anbefalt oppf\u00f8lging og behandling. Oslo: National Centre for Rare Epilepsy-Related Disorders; 2016."},{"key":"835_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrurol.2010.63","volume":"7","author":"MJ Leveridge","year":"2010","unstructured":"Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N. Imaging renal cell carcinoma with ultrasonography, CT and MRI. Nat Rev Urol. 2010;7:311\u201325.","journal-title":"Nat Rev Urol"},{"key":"835_CR33","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.juro.2015.07.126","volume":"195","author":"AS Flum","year":"2016","unstructured":"Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB, Perry KT, Nadler RB. Update on the diagnosis and Management of Renal Angiomyolipoma. J Urol. 2016;195:834\u201346.","journal-title":"J Urol"},{"key":"835_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.ejhg.5200208","volume":"6","author":"N Bradshaw","year":"1998","unstructured":"Bradshaw N, Brewer C, FitzPatrick D, Murray G, Rodgers F, Porteous M, Campbell H. Guidelines and care pathways for genetic diseases: the Scottish collaborative project on tuberous sclerosis. Eur J Hum Genet. 1998;6:445\u201358.","journal-title":"Eur J Hum Genet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0835-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T19:28:53Z","timestamp":1549999733000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0835-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["835"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0835-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"22 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In France, the study was approved by a Medical Ethics Committee (Comit\u00e9 de Protection des Personnes Sud-Est IV, decision L14\u201395) and declared to the Commission Nationale de l\u2019Informatique et des Libert\u00e9s (declaration 09\u201325).In Norway, the study was approved by the Regional Committees for Medical and Health Research Ethics, South-East Region (reference number 2013\/176) and by the data protection officer in Oslo University Hospital (reference number 2013\/3809).Written informed consent to participate was received from patients over 16\u00a0years of age, and from patients\u2019 parents or guardians of patients below 16\u00a0year of age and for those lacking the competence to give consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"In France, the questionnaire was anonymous and the study design was classified as \u2018non-interventional\u2019 by the Ethics Committee. As a result, the need for an informed consent was waived. Written informed consent for publication was received from patients over 16\u00a0years of age, and from patients\u2019 parents or guardians of patients below 16\u00a0years of age and for those lacking the competence to give consent in Norway.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) MG, IC, KKS, declare that they have no competing interests. OR has been investigator in the EXIST-2 trial funded by Novartis. MB have received speaker honoraria from Novartis and is the national coordinator (Norway) of the EXIST-3 trial and an international disease registry collecting data on manifestation and outcomes in patients with tuberous sclerosis complex \u2013 TOSCA, funded by Novartis.KH is participating in the advisory board of The Norwegian Association of Tuberous Sclerosis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"39"}}